{"id":"https://openalex.org/W2560901421","doi":"https://doi.org/10.1182/blood.v126.23.736.736","title":"Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing","display_name":"Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2560901421","doi":"https://doi.org/10.1182/blood.v126.23.736.736","mag":"2560901421"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.736.736","doi":"https://doi.org/10.1182/blood.v126.23.736.736","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.736.736","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048300954","display_name":"Moussab Damlaj","orcid":"https://orcid.org/0000-0001-8326-2193","observed_orcids":["https://orcid.org/0000-0001-8326-2193","https://orcid.org/0009-0008-3591-6322"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moussab Damlaj","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064856519","display_name":"Hassan B. Alkhateeb","orcid":"https://orcid.org/0000-0002-3609-8404","observed_orcids":["https://orcid.org/0000-0002-3609-8404"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hassan B Alkhateeb","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007248698","display_name":"Daniel K. Partain","orcid":"https://orcid.org/0000-0003-1506-304X","observed_orcids":["https://orcid.org/0000-0003-1506-304X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel K. Partain","raw_affiliation_strings":["Department of Internal Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008757704","display_name":"Jehad Almasri","orcid":"https://orcid.org/0000-0001-6098-8450","observed_orcids":["https://orcid.org/0000-0001-6098-8450"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jehad Almasri","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067492340","display_name":"Mehrdad Hefazi","orcid":"https://orcid.org/0000-0001-8860-3380","observed_orcids":["https://orcid.org/0000-0001-8860-3380"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mehrdad Hefazi","raw_affiliation_strings":["Department of Internal Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043033429","display_name":"Shahrukh Khurshid Hashmi","orcid":"https://orcid.org/0000-0002-8914-7927","observed_orcids":["https://orcid.org/0000-0002-8914-7927"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahrukh K. Hashmi","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090561132","display_name":"Dennis A. Gastineau","orcid":"https://orcid.org/0000-0003-2250-9812","observed_orcids":["https://orcid.org/0000-0003-2250-9812"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis A. Gastineau","raw_affiliation_strings":["Mayo Clinic, Rochester, MS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MS","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aref Al-Kali","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015756423","display_name":"Robert Christian Wolf","orcid":"https://orcid.org/0000-0002-5358-5212","observed_orcids":["https://orcid.org/0000-0002-5358-5212"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C Wolf","raw_affiliation_strings":["Department of Pharmacy, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002643270","display_name":"Naseema Gangat","orcid":"https://orcid.org/0000-0002-9104-6172","observed_orcids":["https://orcid.org/0000-0002-9104-6172"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naseema Gangat","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R Litzow","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084606047","display_name":"William J. Hogan","orcid":"https://orcid.org/0000-0002-5841-4105","observed_orcids":["https://orcid.org/0000-0002-5841-4105"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J Hogan","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M Patnaik","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007248698","https://openalex.org/A5008757704","https://openalex.org/A5064856519","https://openalex.org/A5067492340"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.7068,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.75769231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"126","issue":"23","first_page":"736","last_page":"736"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.878000020980835},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.9850000143051147},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.9850000143051147},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.9269999861717224},{"id":"https://openalex.org/keywords/pharmacokinetic-dosing","display_name":"pharmacokinetic dosing","score":0.8209999799728394},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7900000214576721},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8569999933242798},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.7829999923706055},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.7070000171661377},{"id":"https://openalex.org/keywords/graft-versus-leukemia-effect","display_name":"graft-versus-leukemia effect","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.9142294526100159},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8282772302627563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7616025805473328},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.7283738851547241},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.6755936145782471},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5813645720481873},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5190882682800293},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.514700710773468},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47287625074386597},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4526810050010681},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.43862032890319824},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.41497641801834106},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37619537115097046},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35351473093032837},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.21234238147735596},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20620030164718628},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.13596948981285095}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.736.736","doi":"https://doi.org/10.1182/blood.v126.23.736.736","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.736.736","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2345347338","https://openalex.org/W2029173845","https://openalex.org/W2900942034","https://openalex.org/W2890317359","https://openalex.org/W1480670630","https://openalex.org/W2561452209","https://openalex.org/W2493676730","https://openalex.org/W2980367060","https://openalex.org/W2498590734","https://openalex.org/W3010714507"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Fludarabine":[2],"plus":[3,8],"busulfan":[4,73,96,302],"(FB)":[5],"and":[6,71,116,128,160,168,179,198,211,220,234,240,271,303,330,341,381,398,406,410,413,421,436,499,508,512,518,575,619,629],"fludarabine":[7],"melphalan":[9],"(FM)":[10],"are":[11,254],"two":[12],"commonly":[13],"used":[14],"reduced":[15],"intensity":[16],"conditioning":[17,252,647],"(RIC)":[18],"regimens":[19,33],"for":[20,142,347,354,360,379,385,408,415,503,532],"allogeneic":[21],"hematopoietic":[22],"stem":[23],"cell":[24],"transplantation":[25],"(SCT).":[26],"A":[27,317,454],"recent":[28],"analysis":[29,563],"showed":[30],"that":[31,64],"both":[32],"had":[34,306],"similar":[35,502,617],"overall":[36],"survival":[37,478],"(OS)":[38],"but":[39],"relapse":[40,458,533],"incidence":[41,188,391,459],"(RI)":[42,460],"was":[43,138,189,230,350,375,403,461,480,501,541,610],"significantly":[44,455,482,557],"higher":[45,52,276,456],"with":[46,48,69,111,145,310,463,543,546,559,568,579,612,615],"FB":[47,90,137,219,263,281,298,355,380,409,464,486,504,540,606,644],"a":[49,272,275,311,332,521,616,646,657],"trend":[50,273],"towards":[51,274],"non-relapse":[53],"mortality":[54],"(NRM)":[55],"in":[56,136,256,296,426,448,484,633,656],"FM":[57,92,284,361,386,416,428,466,488,506,609],"(Baron":[58],"et":[59],"al.,":[60],"Cancer":[61],"2015).":[62],"However,":[63,496],"cohort":[65,229],"included":[66],"patients":[67,110,154,295,305,321,425,597],"treated":[68],"oral":[70],"intravenous":[72,78,94,301],"without":[74],"pharmakokinetic":[75],"targeting":[76],"of":[77,89,149,226,313,319,324,336,392,431,442,588,595,643],"which":[79],"may":[80],"impact":[81,626],"anti-leukemic":[82],"activity.":[83],"Aim:":[84],"Compare":[85],"transplant":[86,627],"related":[87,566],"outcomes":[88,628],"vs.":[91,264,282,356,465,487,491,505,577],"using":[93,165,175,183,194,203],"(IV)":[95],"targeted":[97],"to":[98,251,369,608],"the":[99,102,176,184,227,289,297,366,427,485,530,589,640],"area":[100],"under":[101],"curve":[103],"(AUC).":[104],"Methods:":[105],"After":[106],"due":[107],"IRB":[108],"approval,":[109],"acute":[112,396],"myelogenous":[113],"leukemia":[114],"(AML)":[115],"myelodysplastic":[117],"syndromes":[118],"(MDS)":[119],"receiving":[120],"RIC-SCT":[121],"from":[122],"2008-2014":[123],"were":[124,131,163,173,181,201,216,288,322,446,564],"identified.":[125,293],"All":[126,153,294],"baseline":[127],"laboratory":[129],"features":[130],"retrospectively":[132],"extracted.":[133],"Busulfan":[134],"dose":[135,334,522,604,622],"0.8":[139],"mg/kg":[140],"IV":[141],"10":[143],"doses":[144],"therapeutic":[146],"AUC":[147,212,308,526,603,621],"target":[148],"900-1500":[150],"mcmol/L":[151,315,328],"(min).":[152,316],"received":[155,300],"T-cell":[156],"replete":[157],"grafts.":[158],"Categorical":[159],"continuous":[161],"variables":[162],"compared":[164,182,607],"Pearson's":[166],"chi-squared":[167],"Wilcoxon/Kruskal-Wallis,":[169],"respectively.":[170,246],"Survival":[171],"estimates":[172],"calculated":[174],"Kaplan-Meier":[177],"method":[178],"curves":[180],"log-rank":[185],"test.":[186],"Cumulative":[187,390],"computed":[190],"as":[191,645],"competing":[192],"events":[193],"Grey's":[195],"model.":[196],"Univariate":[197],"multivariate":[199,538,562],"analyses":[200],"performed":[202],"Cox":[204],"regression":[205],"modeling.":[206],"Results:":[207],"A.":[208],"Baseline":[209,247],"characteristics":[210,248],"monitoring:":[213],"134":[214],"pts":[215],"identified":[217],"(47":[218],"87":[221],"FM).":[222],"Median":[223],"follow":[224,237],"up":[225],"entire":[228],"40":[231],"months":[232],"(0-63.3)":[233],"at":[235,401,467,489],"last":[236],"up,":[238],"60%":[239],"29%":[241],"have":[242],"died":[243,430],"or":[244,534],"relapsed,":[245],"stratified":[249],"according":[250],"regimen":[253],"shown":[255],"table":[257],"1.":[258,661,663],"Younger":[259],"age":[260],"(60":[261],"yrs":[262,266],"61":[265],"FM,":[267],"p":[268,285,515,552,572,583],"=":[269,286,363,388,418,473,516,553,573,584],"0.015)":[270],"CMV":[277],"R-/D-":[278],"status":[279],"(28%":[280],"14%":[283],"0.064)":[287],"only":[290],"significant":[291],"differences":[292],"group":[299,429],"46/47":[304],"evaluable":[307],"data":[309],"range":[312],"732-1354":[314],"total":[318],"19":[320,351],"outside":[323],"range,":[325],"all":[326],"<900":[327],"(min)":[329],"required":[331],"median":[333,345,367],"increase":[335,529],"28.1%":[337],"(3.3-50.2%)":[338],"B.":[339],"Engraftment":[340],"toxicity":[342],"data:":[343],"The":[344,586],"time":[346,368],"platelet":[348],"engraftment":[349,374],"days":[352,358,377,383],"(0-48)":[353],"16":[357],"(14-183)":[359],"(p":[362,387,417,472,494],"0.0023)":[364],"whereas":[365],"absolute":[370],"neutrophil":[371],"count":[372],"(ANC)":[373],"18":[376],"(7-30)":[378],"15":[382],"(11-40)":[384],"0.077).":[389],"grade":[393],"II-IV,":[394],"III-IV":[395],"GVHD":[397,400],"chronic":[399],"2-yr":[402,457,475,497],"57.3%,":[404],"11%":[405],"52.8%":[407],"48.6%,":[411],"17%":[412],"63.4%":[414],"0.73,":[419],"0.4":[420],"0.21,":[422],"respectively).":[423],"Two":[424],"cardiac":[432,438],"causes":[433],"(heart":[434],"failure":[435],"sudden":[437],"arrest).":[439],"No":[440],"cases":[441],"sinusoidal":[443],"obstructive":[444],"syndrome":[445],"observed":[447],"either":[449],"arm":[450],"C.":[451],"Transplant":[452],"outcomes:":[453],"associated":[462,542,558,611],"35.6%":[468],"vs":[469,510],"17.3%,":[470],"respectively":[471,493,514],"0.0058).":[474],"progression":[476],"free":[477],"(PFS)":[479],"also":[481],"lower":[483],"51.2%":[490],"65.1%,":[492],"0.031).":[495],"OS":[498,618],"NRM":[500],"(53.1%":[507],"22.9%":[509],"63.9%":[511],"21.9%,":[513],"0.26":[517],"0.89).":[519],"Necessitating":[520],"adjustment":[523,623],"based":[524],"on":[525,561],"did":[527,624],"not":[528,599,625],"risk":[531],"affect":[535],"NRM.":[536,620],"In":[537],"analysis,":[539],"increased":[544,613],"RI":[545,560,614],"hazard":[547],"ratio":[548],"(HR)":[549],"2.29":[550],"(1.07-4.88;":[551],"0.033).":[554],"Other":[555],"factors":[556],"secondary/therapy":[565],"disease":[567],"HR":[569,580],"2.84":[570],"(1.34-6.02;":[571],"0.0067)":[574],"CR1":[576],"other":[578],"0.39":[581],"(0.17-5.32;":[582],"0.019).":[585],"significance":[587],"results":[590],"remained":[591],"unchanged":[592],"after":[593],"exclusion":[594],"MDS":[596],"(data":[598],"shown)":[600],"Conclusion:":[601],"Despite":[602],"adjustment,":[605],"its":[630],"routine":[631],"use":[632,642],"RIC":[634],"should":[635,652],"be":[636,653],"further":[637],"evaluated.":[638],"Given":[639],"wide":[641],"regimen,":[648],"these":[649],"important":[650],"observations":[651],"prospectively":[654],"studied":[655],"randomized":[658],"fashion.":[659],"Figure":[660,662,664,666],"2.":[665,667],"Disclosures":[668],"Al-Kali:":[669],"Novartis:":[670],"Research":[671],"Funding.":[672],"Wolf:Janssen":[673],"Scientific":[674],"Affairs,":[675],"LLC:":[676],"Consultancy.":[677]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2017-01-06T00:00:00"}